Two New Vaccines Join COVID Fight As China Ships Millions Overseas
Newcomers to Speed Up Slow Domestic Rollout?
Executive Summary
CanSino's adenovirus-based COVID-19 vaccine, along with another from state-owned Sinopharm, have been granted prompt conditional approvals in China, taking to four the number approved in the country and as Beijing ships millions of doses around the world.
You may also be interested in...
‘Reckless’ State Campaigns Seek To Undermine Western COVID-19 Vaccines
China, Iran and especially Russia have launched campaigns aimed at undermining confidence in Western vaccines, especially Pfizer’s, according to two reports.
‘Reckless’ State Campaigns Seek To Undermine Western COVID-19 Vaccines
China, Iran and especially Russia have launched campaigns aimed at undermining confidence in Western vaccines, especially Pfizer’s, according to two reports.
China Grants Conditional Approval To CNBG COVID Vaccine
State-owned China National Biotec Group becomes the first to get the greenlight for its inactivated virus-based vaccine to prevent COVID-19.